21st Healthcare Industry Meeting


October 15, 2014

8:30 - 9:00 Welcome and Registration 
• Prof. Núria Mas, Chair of the Meeting, IESE Business School
• Cándido Pérez Serrano, Partner, KPMG Spain and Coorganizer of the Meeting
• Humberto Arnés, General Manager, Farmaindustria
The Triple Aim: Better Health, Lower Costs and Improved Health Care
What is the current and future global economic landscape? How will the global economy impact the health sector? As financial pressures intensify and the population ages in many countries, many economies face a “triple aim”: better health, lower costs and improved healthcare. Is this a reasonable objective, and if so, what can be done to achieve it?

• Prof. Núria Mas, IESE Business School
Personalized medicine, new technologies, genomics, and treatments capable of curing illnesses that were once considered chronic: these advances will lead to important benefits, as well as significant economic outlays. What are the best options for financing these medical innovations? What is the best way to ensure access to advanced medicine?

• Dr. David Kaplan, Global Leader for Clinical Solutions, Mercer
• Josep Lluís Sanfeliu, Partner, Ysios Capital Partners
• Dr. Josep Santacreu, CEO, DKV Seguros Group

Moderator: Prof. Núria Mas, IESE Business School
10:50 - 11:15Coffee Break
11:15 - 12:00FUTURE TRENDS
Big Data in Health Care
The emergence of big data is already a reality in many industries, and could have far-reaching implications on the healthcare sector. The analysis of big data enables healthcare professionals to identify patterns, better monitor patients, and customize treatments to patient needs. Nonetheless, these opportunities don’t come without risks. What impact will big data have on organizational issues and professional development? How can healthcare professionals leverage this information to make better decisions?

• Keynote speaker: Dr. Stefan Bungart, Leader of GE Software Europe, GE Global Research

Moderator: Prof. Núria Mas, IESE Business School
The healthcare sector is rapidly changing. How can the industry manage its portfolio in this ever-evolving landscape?

• Ángel Fernández, President and General Manager, Spain & Portugal, Merck Sharp & Dohme
• Luis García Bahamonde, Managing Director Iberia, Abbott Diagnostics Division 
• Jaime Grego, President, Laboratorios Leti
• Jordi Ramentol, CEO, Ferrer

Moderator: José Ignacio Rodríguez Prado, Responsible for Life Sciences Industry, KPMG Spain
13:00 - 13:15Break
Managing Healthcare for a Patient-Centric Reality
Hospitals and medical facilities can drive positive change in their internal processes and boost efficiency by integrating by healthcare professionals and other key stakeholders in the decision-making process. In a patient-centric context, healthcare facilities must also strive to further implicate patients and adopt a management framework with a holistic view of patient care.

• Dr. Manel del Castillo, CEO, Hospital de Sant Joan de Déu, Barcelona
• Jesús María Fernández Díaz, International Director, Healthcare Business Unit, Oracle Corporation 
• Dra. M. Dolors Navarro, President, Spanish Patient Forum and Member of the Advisory Committee, European Patients' Forum (EPF)

Moderator: Prof. Jaume Ribera, IESE Business School
14:15 - 15:30Lunch
15:30 - 16:30INNOVATION
The Healthcare Industry: A Catalyst for Innovation
The corporate arena has been a trailblazer for countless innovations that have improved the life of people worldwide. The future is wide open, yet companies can’t spur innovation single-handedly: they require the collaboration of healthcare suppliers. Companies need to work collaboratively with healthcare vendors, but first need to provide sound arguments to prove that innovation is a worthwhile investment capable of generating added value to the sector and society at large. What indicators should companies use to support their arguments? How can innovation be monetized? What are the keys to fostering ongoing innovation throughout the healthcare ecosystem?

• Javier Colás, Managing Director, Medtronic Ibérica, S.A.
• Ludovic Helfgott, President, AstraZeneca Spain
• Eduardo Rodríguez Urcelay, CEO, Diaverum Spain

Moderator: Prof. Núria Mas, IESE Business School
16:30 - 17:30 GLOBALIZATION
Health: A Global Need That Demands Local Measures
Globalization has triggered the expansion of the healthcare sector, traditionally perceived as a local industry, and simultaneously ushered in new rules of the game. Companies that innovate and operate in different countries need to strike a balance between a designing a solid global strategy and adapting to local market conditions.

• Vera Nwanze, Country Group Head, English West Africa, Novartis Pharma AG
• Nuria Pascual, CVP Finance Director & IRO, Grifols S.A.
• Eduardo Sanchiz, CEO, Almirall

Moderator: Prof. Pedro Nueno, IESE Business School
17:30 - 18:00Coffee Break
18:00 - 18:45REGULATIONS
The regulatory framework in the healthcare industry is changing at a dramatic pace. Some industry actors are concerned with risk management of certain treatments, while the U.S. Food and Drug Administration is developing a new safety system that encompasses both medicines and medical technology. At the same time, there is increasing pressure to reevaluate the portfolio of services. Does excessive regulation pose any risks?

• Belén Crespo, Director, Spanish Agency of Medicines and Medical Devices 
• Dr. Ingrid Klingmann, Chairman of the Board, European Forum for Good Clinical Practice (EFGCP)

Moderator: Cándido Pérez Serrano, Partner, Head of Infraestructure, Transport, Government and Health, KPMG Spain
18:45 - 19:15Reflections and Remarks
• Cándido Pérez Serrano, Partner, KPMG Spain
• Prof. Núria Mas, IESE Business School
• Prof. Pedro Nueno, IESE Business School
19:15 Closing Session
• Roser Fernández, Secretary General, Health Department, Government of Catalonia 

• Prof. Núria Mas, Chair of the Meeting, IESE Business School
• Prof. Pedro Nueno, Founding Chair of the Meeting, IESE Business School
• Cándido Pérez Serrano, Partner, KPMG Spain and Coorganizer of the Meeting
• Daniel Carreño, President, Fenin and CEO Spain & Portugal, General Electric